Adherence to European Society of Cardiology Guideline-directed Medical Therapies for Patients With Chronic Heart Failure in France
NCT ID: NCT07022379
Last Updated: 2025-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17551 participants
OBSERVATIONAL
2021-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participant population were adults with heart failure using the Satelia®Cardio web application to remotely monitor their condition.
The main questions it aims to answer are:
* to compare the prescription of treatments (including doses, and distribution of patients according to various therapeutic classes recommend for heart failure) with ESC recommendations to see to what extent GDMTs are adhered to.
* to quantify the association between the presence of treatments and the risk of alerts/hospitalizations and overall death and as a function of LVEF using telemonitoring.
* to evaluate the adherence across patient profiles and cardiologist practices (outpatient vs. hospital-based).
Participants will complete follow-up, quality-of-life and patient support questionnaires and provide data regarding their treatments on the web application.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Back-to-home Support Program for Hospitalized Patients for Heart Failure
NCT05566145
Cohort of Heart Failure Patients
NCT03422991
Heart Failure Events Reduction With Remote Monitoring and eHealth Support Investigator Initiated Trial
NCT03663907
Blind Assessment of the Concordance Between the Administered Treatment and the Recommendations of a Medical Algorithm Decision Support Software in Systolic Heart Failure
NCT02900547
French Observatory of Acute Heart Failure
NCT01080937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Key clinical parameters such as age, gender, NYHA class, LVEF, and HF etiology were analyzed. Prescribed therapies including ACEi/ARB/ARNis, beta-blockers, MRAs, and SGLT2 inhibitors, were compared against the European Society of Cardiology (ESC) guideline-directed medical therapies (GDMTs).
Adherence was evaluated across patient profiles and cardiologist practices (outpatient vs. hospital-based) in France.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart failure patients remotely monitored with Satelia® Cardio program with SGLT2i treatment
Heart failure patients remotely monitored with Satelia® Cardio program without SGLT2i treatment
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients diagnosed with heart failure whatever the aetiology:
Especially patients who undergone:
Hospitalization within the previous 12 months, OR patients with NYHA class II or more, and BNP \> 100 pg/ml OR NT-proBNP \> 1000 pg/ml.
Exclusion Criteria
* Pregnant women
* Physical or psychological impossibility for the patient or carer to use the digital medical device according to the judgment of the doctor wishing to include the patient in the remote medical monitoring project.
18 Years
105 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sophie NISSE-DURGEAT
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sophie NISSE-DURGEAT
Nicolas Girerd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Affairs Department, NP Medical
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Girerd N, Barbet V, Seronde MF, Benchimol H, Jagu A, Tartiere JM, Hanon O, Picard F, Lafitte S, Lemaitre M, Pages N, Nisse-Durgeat S, Jourdain P. Association of a remote monitoring programme with all-cause mortality and hospitalizations in patients with heart failure: National-scale, real-world evidence from a 3-year propensity score analysis of the TELESAT-HF study. Eur J Heart Fail. 2025 Sep;27(9):1658-1669. doi: 10.1002/ejhf.3563. Epub 2025 Jan 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-REMOTE-HF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.